Fiche publication
Date publication
mars 2021
Journal
Anticancer research
Auteurs
Membres identifiés du Cancéropôle Est :
Dr DEBREUVE-THERESETTE Adeline
Tous les auteurs :
Marchand-Crety C, Pascard M, Debreuve-Theresette A, Ettalhaoui L, Schvartz C, Zalzali M, Brugel M, Bellefqih S, Servagi-Vernat S
Lien Pubmed
Résumé
Anaplastic thyroid carcinoma (ATC) is the least common but most lethal of thyroid cancer, despite various therapeutic options, with limited efficacy. In order to help therapeutic decision-making, the purpose of this study was to develop a new prognostic score providing survival estimates in patients with ATC.
Mots clés
Anaplastic thyroid carcinoma, clinical decision-making, prognosis, propensity score, survival
Référence
Anticancer Res. 2021 Mar;41(3):1555-1561